Andrew J Fisher

Title: Innovations of Andrew J Fisher

Introduction

Andrew J Fisher is a notable inventor based in Davis, California. He has made significant contributions to the field of genetic engineering and molecular biology. With a total of three patents to his name, Fisher's work focuses on advancing methods for genome editing and the development of novel therapeutic approaches.

Latest Patents

Fisher's latest patents include groundbreaking inventions such as "Fusion proteins and methods for site-directed genome editing." This invention provides methods and compositions for modifying target sites within nucleic acid molecules. The methods utilize adenosine deaminases that act on RNA (ADARs) to modify target sites within DNA-RNA hybrid molecules. Additionally, the patent describes ADAR2 variant polypeptides and fusion proteins that comprise an ADAR catalytic domain and a hybrid nucleic acid binding domain. These innovations also encompass methods for preventing and treating genetic disorders.

Another significant patent is for "Sialyltransferase variants having neosialidase activity." This invention details α2-6-Sialyltransferase (2,6ST) variants that exhibit improved α2-6-specific sialidase activity compared to native 2,6ST enzymes. The variants include GT80 sialyltransferases such as Pd2,6ST. The patent also describes methods for producing de-sialylated products and screening sialidase activity.

Career Highlights

Fisher is affiliated with the University of California, where he conducts his research and development work. His academic background and ongoing research contribute to the advancement of genetic technologies and therapeutic solutions.

Collaborations

Fisher collaborates with talented individuals such as Yuxuan Zheng and Claire Lorenzo. Their combined expertise enhances the innovative potential of their projects and contributes to the success of their research endeavors.

Conclusion

Andrew J Fisher is a prominent inventor whose work in genetic engineering has led to significant advancements in genome editing and therapeutic methods. His contributions continue to shape the future of molecular biology and medicine.